REQUEST A DEMO
Total
USD $0.00
Search more companies

Galpharmacia D.O.O. Beograd (Serbia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Galpharmacia D.O.O. Beograd Profile Updated: October 13, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2021 Available in: English Download a sample report

Galpharmacia D.O.O. Beograd is an enterprise based in Serbia. Its main office is in Belgrade. The enterprise currently operates in the Pharmaceutical Preparation Manufacturing sector. It was first established on 2012. It currently has a total number of 47 (2020) employees. The company’s latest financial report indicates a net sales revenue drop of 19.01% in 2021. Its’ total assets recorded a growth of 24.48%. In, 2021, the company’s net profit margin increased by 9.71%.

Headquarters
Dr. Drage Ljocic 3
Belgrade; Belgrade; Postal Code: 11060

Contact Details: Purchase the Galpharmacia D.O.O. Beograd report to view the information.

Website: http://www.galenikapharmacia.co.rs

Basic Information
Total Employees:
Purchase the Galpharmacia D.O.O. Beograd report to view the information.
Outstanding Shares:
Purchase the Galpharmacia D.O.O. Beograd report to view the information.
Registered Capital:
Purchase the Galpharmacia D.O.O. Beograd report to view the information.
Incorporation Date:
2012
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Galenika Tehnoplast
100%
Inseas - U Prinudnoj Likvidaciji
100%
Lv Energy D.O.O.
100%
Company Performance
Financial values in the chart are available after Galpharmacia D.O.O. Beograd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
-19.01%
Total operating revenue
-19.55%
Operating profit (EBIT)
39.29%
EBITDA
15.87%
Net Profit (Loss) for the Period
159.44%
Total assets
24.48%
Total equity
-6.31%
Operating Profit Margin (ROS)
8.02%
Net Profit Margin
9.71%
Return on Equity (ROE)
33.12%
Debt to Equity Ratio
19.05%
Quick Ratio
0.47%
Cash Ratio
-0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?